Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Cardiology

Clinical Pharmacology

Effects of lowest-dose vs highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: An optical coherence tomography analysis

Heart and Vessels | Jul 29, 2018 Clinical Pharmacology

Cardiovascular outcomes including those occurring during extended follow-up of the AIM-HIGH trial cohort

Journal of Clinical Lipidology | Jul 28, 2018 Clinical Pharmacology

Usefulness of canakinumab to improve exercise capacity in patients with chronic systolic heart failure and elevated C-reactive protein

American Journal of Cardiology | Jul 28, 2018 Clinical Pharmacology

Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome

Heart | Jul 27, 2018 Clinical Pharmacology

Real clinical experiences of dual vs triple antithrombotic therapy after percutaneous coronary intervention

Catheterization and Cardiovascular Interventions | Jul 27, 2018 Clinical Pharmacology

Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

ESC Heart Failure | Jul 27, 2018 Clinical Pharmacology

Meta-analysis comparing dual antiplatelet therapy vs single antiplatelet therapy following transcatheter aortic valve implantation

American Journal of Cardiology | Jul 25, 2018 Clinical Pharmacology

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: Population based cohort study

BMJ | Jul 23, 2018 Clinical Pharmacology

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Cardiovascular Diabetology | Jul 23, 2018 Clinical Pharmacology

Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial

Atherosclerosis | Jul 22, 2018 Clinical Pharmacology

« Prev 1 … 134 135 136 137 138 … 163 Next »

Effects of lowest-dose vs highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: An optical coherence tomography analysis

Cardiovascular outcomes including those occurring during extended follow-up of the AIM-HIGH trial cohort

Usefulness of canakinumab to improve exercise capacity in patients with chronic systolic heart failure and elevated C-reactive protein

Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome

Real clinical experiences of dual vs triple antithrombotic therapy after percutaneous coronary intervention

Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

Meta-analysis comparing dual antiplatelet therapy vs single antiplatelet therapy following transcatheter aortic valve implantation

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: Population based cohort study

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Effects of lowest-dose vs highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: An optical coherence tomography analysis

Cardiovascular outcomes including those occurring during extended follow-up of the AIM-HIGH trial cohort

Usefulness of canakinumab to improve exercise capacity in patients with chronic systolic heart failure and elevated C-reactive protein

Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome

Real clinical experiences of dual vs triple antithrombotic therapy after percutaneous coronary intervention

Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

Meta-analysis comparing dual antiplatelet therapy vs single antiplatelet therapy following transcatheter aortic valve implantation

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: Population based cohort study

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic